Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +739 | +2.27% | $0.00 | 33.3K | Feb 15, 2023 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$16.1K | -340 | -1.02% | $47.29 | 33K | Feb 15, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -739 | -100% | $0.00* | 0 | Feb 15, 2023 | Common Stock | 739 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |